These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20209732)

  • 1. Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programs.
    De Wals P; Boulianne N; Sévin E; Ouakki M; Deceuninck G; Guay M
    Can J Public Health; 2009; 100(6):413-6. PubMed ID: 20209732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of pneumococcal vaccines in the Nordic region of Nunavik, province of Quebec, Canada.
    Cléophat JE; Le Meur JB; Proulx JF; De Wals P
    Can J Public Health; 2014 May; 105(4):e268-72. PubMed ID: 25166129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    De Wals P; Lefebvre B; Markowski F; Deceuninck G; Defay F; Douville-Fradet M; Landry M
    Vaccine; 2014 Mar; 32(13):1501-6. PubMed ID: 24486346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    Wals PD; Carbon M; Sévin E; Deceuninck G; Ouakki M
    Pediatr Infect Dis J; 2009 Sep; 28(9):e271-5. PubMed ID: 19710582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Possible Inclusion of Pneumococcal Conjugate Vaccine into the National Immunization Program for Infants in India.
    Ghia C; Wasserman M; Fletcher M; Farkouh R; Rambhad G
    Value Health Reg Issues; 2018 May; 15():99-105. PubMed ID: 29655052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; Baquero F; Hernández-Sampelayo T; Otheo E; Méndez C;
    PLoS One; 2017; 12(2):e0172222. PubMed ID: 28207888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada.
    De Wals P; Lefebvre B; Defay F; Deceuninck G; Boulianne N
    Vaccine; 2012 Oct; 30(45):6416-20. PubMed ID: 22921290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful introduction of an underutilized elderly pneumococcal vaccine in a national immunization program by integrating the pre-existing public health infrastructure.
    Yang TU; Kim E; Park YJ; Kim D; Kwon YH; Shin JK; Park O
    Vaccine; 2016 Mar; 34(13):1623-1629. PubMed ID: 26850759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parental knowledge, attitudes and perception of pneumococcal disease and pneumococcal conjugate vaccines in Singapore: a questionnaire-based assessment.
    How CH; Phua See Chun P; Shafi F; Jakes RW
    BMC Public Health; 2016 Sep; 16(1):923. PubMed ID: 27590503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of different vaccine schedules for heptavalent and 13-valent conjugate vaccines against pneumococcal disease in the Community of Madrid.
    Latasa P; Ordobás M; Garrido-Estepa M; Gil de Miguel A; Sanz JC; Barranco MD; Insúa E; García-Comas L
    Vaccine; 2017 Sep; 35(40):5381-5387. PubMed ID: 28807606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to pneumococcal conjugate vaccination schedule and uptake rate as compared to the established diphtheria-tetanus-acellular pertussis vaccination in Cyprus.
    Hadjipanayis A; Efstathiou E; Michaelidou K; Papaevangelou V
    Vaccine; 2018 Sep; 36(38):5685-5691. PubMed ID: 30115523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of a 3 + 0 pneumococcal conjugate vaccine schedule against invasive pneumococcal disease among a birth cohort of 1.4 million children in Australia.
    Gidding HF; McCallum L; Fathima P; Moore HC; Snelling TL; Blyth CC; Jayasinghe S; Giele C; de Klerk N; Andrews RM; McIntyre PB;
    Vaccine; 2018 May; 36(19):2650-2656. PubMed ID: 29627233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a 3-dose pneumococcal conjugate vaccine program in the province of Quebec, Canada.
    Poirier B; De Wals P; Petit G; Erickson LJ; Pépin J
    Vaccine; 2009 Nov; 27(50):7105-9. PubMed ID: 19786137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timeliness and risk factors associated with delay for pneumococcal conjugate 10-valent routine immunization in Brazilian children.
    Sartori AL; Minamisava R; Afonso ET; Policena GM; Pessoni GC; Bierrenbach AL; Andrade AL
    Vaccine; 2017 Feb; 35(7):1030-1036. PubMed ID: 28108230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: an evaluation using existing data.
    Picón T; Alonso L; García Gabarrot G; Speranza N; Casas M; Arrieta F; Camou T; Rosa R; De Oliveira LH; Verani JR
    Vaccine; 2013 Jul; 31 Suppl 3():C109-13. PubMed ID: 23777683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider adoption of pneumococcal conjugate vaccine and the impact of vaccine shortages.
    Daley MF; Crane LA; Beaty BL; Barrow J; Pearson K; Stevenson JM; Berman S; Kempe A
    Ambul Pediatr; 2005; 5(3):157-64. PubMed ID: 15913409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.
    Luca DL; Kwong JC; Chu A; Sander B; O'Reilly R; McGeer AJ; Bloom DE
    Clin Infect Dis; 2018 Feb; 66(4):541-547. PubMed ID: 29029063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician perspectives regarding pneumococcal conjugate vaccine.
    Schaffer SJ; Szilagyi PG; Shone LP; Ambrose SJ; Dunn MK; Barth RD; Edwards K; Weinberg GA; Balter S; Schwartz B
    Pediatrics; 2002 Dec; 110(6):e68. PubMed ID: 12456935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada.
    Deceuninck G; De Wals P; Boulianne N; De Serres G
    Pediatr Infect Dis J; 2010 Jun; 29(6):546-9. PubMed ID: 20125062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.